{"title":"化疗患者多发性硬化疗法","authors":"T. Postert","doi":"10.1055/S-0034-1395787","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":113005,"journal":{"name":"Thieme Case Report","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alemtuzumab – Behandlung der Multiplen Sklerose (Sponsor: Genzyme GmbH)\",\"authors\":\"T. Postert\",\"doi\":\"10.1055/S-0034-1395787\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":113005,\"journal\":{\"name\":\"Thieme Case Report\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thieme Case Report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/S-0034-1395787\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thieme Case Report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/S-0034-1395787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}